Why is This Science Hero Leaving Harvard to Pursue a CURE for Type 1 Diabetes? | Douglas Melton

On April 5, 2022, Douglas Melton, one of the leading stem cell researchers in the world, is leaving Harvard University to join Vertex Pharmaceuticals full time, where he says he will pursue his deeply personal, decades-long quest to create cell therapies for type 1 diabetes. Both his adult children have the disease, which affects the regulation of blood sugar and affects 1.9 million Americans. So what is T1D, who is Douglas Melton, and why is Dr. Melton leaving Harvard to pursue a cure for this terrible disease?

Join Robinhood with my link and we'll both get a free stock 🤝
https://join.robinhood.com/zhijiec

My Favorite Books on Biotech and Investing
The Code Breaker: Jennifer Doudna, Gene Editing, and the Future of the Human Race
https://amzn.to/3rgGAve

#Diabetes
#VRTX
#DouglasMelton
#VX880
#T1D
#Vertex
#Semma
#StemCell
#CellTherapy
#CathyWood
#ARKG
#Stock
#BiotechInvestor

0:00 Introduction: Douglas Melton Leaves Harvard to Join Vertex
1:26 What is Cell Therapy?
3:54 What is Type 1 Diabetes?
4:44 Douglas Melton and His Scientific Breakthrough
6:41 Dr. Melton on a Potential Cure for Type 1 Diabetes
8:47 VX-880 Program Update
10:16 VX-880 Clinical Hold Lifted by FDA
10:37 Details on VX-880 Clinical Trial
12:10 Subscribe For Future Updates

***Disclaimer
I (Biotech Investor) hold a Ph.D. degree in life science and conducted 5 years of postdoctoral training in molecular biophysics at UC Berkeley. I am currently a full-time employee of a clinical-stage biopharmaceutical company, conducting early-stage drug discovery research. I have no professional affiliation with any of the companies or stocks discussed on this channel. This video is strictly for educational and entertainment purposes, and none of the contents in the video are for medical or financial/investment advice. I have no obligation to update, change or correct any information described in this video as news and stock prices change. The thoughts described in this channel are my own and do not reflect the company that I work for. This is not a solicitation to invest in any company I discussed in this channel, and I am not a financial or medical advisor. Investment involves risks and past performance should not be used as a gauge for future success. Seek a financial advisor to determine the appropriate investment strategies for your given circumstances. Investors should obtain their own independent financial advice and understand the risks associated with investment products/ services before making investment decisions.